RSR to Collect Data Related to Opioid Use
Data on how medication-assisted treatment (MAT) is being implemented in Ryan White HIV/AIDS Program (RWHAP) agencies will soon be gathered in the Ryan White Services Report (RSR) Provider Report. This new effort is in response to the national opioid crisis, which was declared a public health emergency in 2017 by the U.S. Department of Health and Human Services (HHS).
Information on MAT will be gathered in order to improve understanding of the opioid crisis and provide information on the scope of service provision and gaps in service coverage.
The New RSR Questions
HRSA’s HIV/AIDS Bureau (HAB) will add three questions to the 2018 RWHAP Services Report (RSR), which will report services provided in calendar year 2018 and will be submitted in March 2019.
The opioid-related questions included the following:
- Within your organization/agency, identify the number of physicians, nurse practitioners, or physician assistants who obtained a Drug Addiction Treatment Act of 2000 (DATA) waiver to treat opioid use disorder with medications (MAT, e.g. buprenorphine) specifically approved by the U.S. Food and Drug Administration (FDA)?
- How many of the above physicians, nurse practitioners, or physician assistants prescribed MAT (e.g. buprenorphine, vivitrol) for opioid use disorders in the reporting year?
- How many clients were treated with MAT during the reporting period?
- Questions related to these changes can be submitted via email.
Data collected will be reported in aggregate and changes to the client-level data submission will not be required.
HAB will provide technical assistance to recipients/subrecipients in reporting the new data elements.